Tools

LEADER 03556cam 2200625 i 4500

001 on1112073384;

003 OCoLC;

005 20210716124247.0;

006 m o d f ;

007 cr |||||||||||;

008 190812m20199999dcua ob f000 0 eng c;

010 a| 2019396814;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

050 4 a| KF26b| .F5 2019;

074 a| 1038-C (online);

086 0 a| Y 4.F 49:S.HRG.116-267;

086 0 a| Y 4.F 49:S.HRG.116-39;

086 0 a| Y 4.F 49:S.HRG.116-415;

245 10 a| Drug pricing in America :b| a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2019-;

300 a| 1 online resource (volumes).;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| S. hrg.;

500 a| "Serial no. 116-267"--Pt. 1.;

500 a| "January 29, 2019"--Pt. 1.;

500 a| "February 26, 2019"--Pt. 2.;

500 a| "Serial no. 116-39"--Pt. 2.;

500 a| "April 9, 2019"--Pt. 3.;

500 a| "Serial no. 116-415"--Pt. 3.;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| "Hearing witnesses: Miller, Steve, M.D., executive vice president and chief clinical officer, Cigna Corporation, Bloomfield, CT; Rice, Derica, executive vice president, CVS Health; and president, CVS Caremark, Woonsocket, RI; Fleming, William K., Pharm.D., segment president, healthcare services, Humana, Inc., Louisville, KY; Prince, John M., chief executive officer, OptumRx, Minnetonka, MN; Kolar, Mike, interim president and CEO, Prime Therapeutics, LLC, Eagan, MN."--Pt. 3.;

511 0 a| "Hearing witnesses: Sego, Kathy, mother of a child with insulin-dependent diabetes, Madison, IN; Holtz-Eakin, Douglas, Ph.D., president, American Action Forum, Washington, DC; Miller, Mark, Ph.D., executive vice president of health care, Laura and John Arnold Foundation, Houston, TX; Bach, Peter B., M.D., director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY."--Pt. 1.;

518 a| Date of hearing: 2019-01-29--Pt. 1.;

518 a| Date of hearing: 2019-04-09--Pt. 3.;

588 a| Description based on online resource; title from PDF, pt. 2, title page (govinfo, viewed Aug. 12, 2019).;

650 0 a| Prescription pricingz| United States.=| ^A5242;

650 0 a| Drugsz| United Statesx| Cost control.=| ^A640;

650 0 a| Pharmaceutical industryz| United States.=| ^A638;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. Senate. Committee on Finance.t| Drug pricing in Americaw| (OCoLC)1117337783;

776 08 i| Microfiche version:a| United States. Congress. Senate. Committee on Finance.t| Drug pricing in Americaw| (OCoLC)1230256473;

856 40 u| https://purl.fdlp.gov/GPO/gpo124181;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5171876;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5171876-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 9/17/2019x| EDOCUMENTz| JERESOURCE;

Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2019-
Description	1 online resource (volumes).
Supplemental Content	https://purl.fdlp.gov/GPO/gpo124181
Subjects	Drugs--Prices. --Government policy. --United States. Prescription pricing--United States. Drugs--United States. --Cost control. Pharmaceutical industry--United States.

Series	S. hrg. United States. Congress. Senate. S. hrg. ^A500722
General note	"Serial no. 116-267"--Pt. 1.
General note	"January 29, 2019"--Pt. 1.
General note	"February 26, 2019"--Pt. 2.
General note	"Serial no. 116-39"--Pt. 2.
General note	"April 9, 2019"--Pt. 3.
General note	"Serial no. 116-415"--Pt. 3.
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	"Hearing witnesses: Miller, Steve, M.D., executive vice president and chief clinical officer, Cigna Corporation, Bloomfield, CT; Rice, Derica, executive vice president, CVS Health; and president, CVS Caremark, Woonsocket, RI; Fleming, William K., Pharm.D., segment president, healthcare services, Humana, Inc., Louisville, KY; Prince, John M., chief executive officer, OptumRx, Minnetonka, MN; Kolar, Mike, interim president and CEO, Prime Therapeutics, LLC, Eagan, MN."--Pt. 3.
Performer	"Hearing witnesses: Sego, Kathy, mother of a child with insulin-dependent diabetes, Madison, IN; Holtz-Eakin, Douglas, Ph.D., president, American Action Forum, Washington, DC; Miller, Mark, Ph.D., executive vice president of health care, Laura and John Arnold Foundation, Houston, TX; Bach, Peter B., M.D., director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY."--Pt. 1.
Date/time/place of a event note	Date of hearing: 2019-01-29--Pt. 1.
Date/time/place of a event note	Date of hearing: 2019-04-09--Pt. 3.
Source of description	Description based on online resource; title from PDF, pt. 2, title page (govinfo, viewed Aug. 12, 2019).
Issued in other form	Print version: United States. Congress. Senate. Committee on Finance. Drug pricing in America
Issued in other form	Microfiche version: United States. Congress. Senate. Committee on Finance. Drug pricing in America
Genre/form	Legislative hearings.
LCCN	2019396814
GPO item number	1038-C (online)
Govt. docs number	Y 4.F 49:S.HRG.116-267
Govt. docs number	Y 4.F 49:S.HRG.116-39
Govt. docs number	Y 4.F 49:S.HRG.116-415

Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session.

Click here for more information about this title